Massachusetts Financial Services
SRNE

Massachusetts Financial Services’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Massachusetts Financial Services’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-26,973
Closed -$261K – 952
2021
Q2 		$261K Sell
26,973
-75,344
-74% -$600K ﹤0.01% 898
2021
Q1 		$846K Sell
102,317
-107,932
-51% -$1.14M ﹤0.01% 855
2020
Q4 		$1.44M Buy
+210,249
New +$1.69M ﹤0.01% 770

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Massachusetts Financial Services's SRNE Position: Q3 2021 in Review

Massachusetts Financial Services sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2021, closing a stake of 26,973 shares — an estimated $261K sold.

Massachusetts Financial Services first reported a position in SRNE in Q4 2020 and held it in 3 quarters. The position peaked at $1.44M in Q4 2020. 220 funds tracked by Wall St. Rank hold SRNE as of Q3 2021.

  • Massachusetts Financial Services reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
  • Massachusetts Financial Services sold 26,973 Sorrento Therapeutics, Inc. shares in Q3 2021, an estimated $261K.
  • Massachusetts Financial Services first reported a position in Sorrento Therapeutics, Inc. in Q4 2020 and held it in 3 quarters.
  • Massachusetts Financial Services's Sorrento Therapeutics, Inc. position peaked at $1.44M in Q4 2020.
  • 220 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2021.

Based on Massachusetts Financial Services's 13F filing for Q3 2021, filed 10 Nov 2021.